Triple‐negative breast cancer (TNBC) is an aggressive breast cancer subtype, which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor‐2 (HER‐2).1 This evidence concerns the gene ERBB2 and breast carcinoma.